These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33642532)

  • 21. Local axonal protection by WldS as revealed by conditional regulation of protein stability.
    Wang JT; Medress ZA; Vargas ME; Barres BA
    Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10093-100. PubMed ID: 26209654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging evidence for compromised axonal bioenergetics and axoglial metabolic coupling as drivers of neurodegeneration.
    Beirowski B
    Neurobiol Dis; 2022 Aug; 170():105751. PubMed ID: 35569720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degeneration of neuronal cell bodies following axonal injury in Wld(S) mice.
    Wang AL; Yuan M; Neufeld AH
    J Neurosci Res; 2006 Dec; 84(8):1799-807. PubMed ID: 17022038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of Wallerian degeneration and nerve growth factor withdrawal-induced pruning of axons of sympathetic neurons by the proteasome and the MEK/Erk pathway.
    MacInnis BL; Campenot RB
    Mol Cell Neurosci; 2005 Mar; 28(3):430-9. PubMed ID: 15737734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid depletion of ESCRT protein Vps4 underlies injury-induced autophagic impediment and Wallerian degeneration.
    Wang H; Wang X; Zhang K; Wang Q; Cao X; Wang Z; Zhang S; Li A; Liu K; Fang Y
    Sci Adv; 2019 Feb; 5(2):eaav4971. PubMed ID: 30788439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol abolishes resistance to axonal degeneration in slow Wallerian degeneration (WldS) mice: activation of SIRT2, an NAD-dependent tubulin deacetylase.
    Suzuki K; Koike T
    Biochem Biophys Res Commun; 2007 Aug; 359(3):665-71. PubMed ID: 17560549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluororuby as a marker for detection of acute axonal injury in rat spinal cord.
    Lu J; Ashwell KW; Hayek R; Waite P
    Brain Res; 2001 Oct; 915(1):118-23. PubMed ID: 11578629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative and qualitative analysis of Wallerian degeneration using restricted axonal labelling in YFP-H mice.
    Beirowski B; Berek L; Adalbert R; Wagner D; Grumme DS; Addicks K; Ribchester RR; Coleman MP
    J Neurosci Methods; 2004 Mar; 134(1):23-35. PubMed ID: 15102500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Traumatic brain injury-induced axonal phenotypes react differently to treatment.
    Hånell A; Greer JE; McGinn MJ; Povlishock JT
    Acta Neuropathol; 2015 Feb; 129(2):317-32. PubMed ID: 25528329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic and histochemical analysis of proteins involved in the dying-back-type of axonal degeneration in the gracile axonal dystrophy (gad) mouse.
    Goto A; Wang YL; Kabuta T; Setsuie R; Osaka H; Sawa A; Ishiura S; Wada K
    Neurochem Int; 2009; 54(5-6):330-8. PubMed ID: 19154771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wallerian degeneration in the optic nerve stretch-injury model of traumatic brain injury: a stereological analysis.
    Maxwell WL; Bartlett E; Morgan H
    J Neurotrauma; 2015 Jun; 32(11):780-90. PubMed ID: 25333317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motor axon excitability during Wallerian degeneration.
    Moldovan M; Alvarez S; Krarup C
    Brain; 2009 Feb; 132(Pt 2):511-23. PubMed ID: 19074190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel role of SARM1 mediated axonal degeneration in the pathogenesis of rabies.
    Sundaramoorthy V; Green D; Locke K; O'Brien CM; Dearnley M; Bingham J
    PLoS Pathog; 2020 Feb; 16(2):e1008343. PubMed ID: 32069324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic aspects of neuronal degeneration: From a NAD
    Sasaki Y
    Neurosci Res; 2019 Feb; 139():9-20. PubMed ID: 30006197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Over-expression of alpha-synuclein in the nervous system enhances axonal degeneration after peripheral nerve lesion in a transgenic mouse strain.
    Siebert H; Kahle PJ; Kramer ML; Isik T; Schlüter OM; Schulz-Schaeffer WJ; Brück W
    J Neurochem; 2010 Aug; 114(4):1007-18. PubMed ID: 20524960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Avian axons undergo Wallerian degeneration after injury and stress.
    Bramley JC; Collins SV; Clark KB; Buchser WJ
    J Comp Physiol A Neuroethol Sens Neural Behav Physiol; 2016 Nov; 202(11):813-822. PubMed ID: 27614771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of axonal degeneration: parallels between Wallerian degeneration and vincristine neuropathy.
    Wang MS; Wu Y; Culver DG; Glass JD
    J Neuropathol Exp Neurol; 2000 Jul; 59(7):599-606. PubMed ID: 10901231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demyelination, and remyelination by Schwann cells and oligodendrocytes after kainate-induced neuronal depletion in the central nervous system.
    Dusart I; Marty S; Peschanski M
    Neuroscience; 1992 Nov; 51(1):137-48. PubMed ID: 1465177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
    J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pivotal roles for membrane phospholipids in axonal degeneration.
    Almasieh M; Faris H; Levin LA
    Int J Biochem Cell Biol; 2022 Sep; 150():106264. PubMed ID: 35868612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.